Kevin Hofer is a Wilderness Systems pro staffer from Mendocino County, California. Lingcod are a voracious deep-water fish ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs containing GLP-1, a hormone that slows digestion and helps with sustained ...

SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge announces a $300 million funding round.

Metformin is a type 2 diabetes medication which may impact weight loss. Read our expert guide on how metformin works and its potential impact on weight loss.

If your weight loss journey involves a specific diet plan besides calorie-cutting — such as a Mediterranean diet, plant-based diet, or keto diet — you can choose to include artificial ...